Hypertension therapy with propanolol and hydralazine
Berglund, G.; Hansson, L.
Lakartidningen 68(44): 5009-5012
1971
ISSN/ISBN: 0023-7205 PMID: 5135956 Document Number: 38356
Document emailed within 1 workday
Related Documents
Shepherd, A.M.; Ludden, T.M.; Haegele, K.D.; Talseth, T.; McNay, J.L. 1979: Pharmacokinetics of hydralazine, apparent hydralazine and hydralazine pyruvic acid hydrazone in humans Research Communications in Chemical Pathology and Pharmacology 26(1): 129-144Talseth, T.; Haegele, K.D.; McNay, J.L.; Skrdlant, H.B.; Clementi, W.A.; Shepherd, A.M. 1979: Pharmacokinetics and cardiovascular effects in rabbits of a major hydralazine metabolite, the hydralazine pyruvic-acid hydrazone Journal of Pharmacology and Experimental Therapeutics 211(3): 509-513
Cotton, D.B.; Gonik, B.; Dorman, K.F. 1985: Cardiovascular alterations in severe pregnancy-induced hypertension seen with an intravenously given hydralazine bolus Surgery Gynecology and Obstetrics 161(3): 240-244
Laslett, L.J.; DeMaria, A.N.; Amsterdam, E.A.; Mason, D.T. 1978: Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy Archives of Internal Medicine 138(5): 819-820
Barbeau, A. 1973: Treatment of essential familial tremor with propanolol L'Union Medicale du Canada 102(4): 899-902
Löllgen, H.; Schmidt, A.; Upmeyer, H.J. 1986: Double-blind comparison of fixed combination preparations of a beta blocker and a diuretic and beta blocker, a diuretic and hydralazine in patients with coronary heart disease and arterial hypertension Medizinische Klinik 81(23): 745-750
Meka, V.S.; Songa, A.S.; Nali, S.R.; Battu, J.R.; Kolapalli, V.R.M. 2012: Design and in vitro evaluation of effervescent gastric floating drug delivery systems of propanolol HCl Investigacion Clinica 53(1): 60-70
Kahn, M.; Luton, J.P.; Ducimetière, P.; Joly, J.; Bricaire, H. 1974: Propanolol and the Achilles reflexogram. Comparison with the action on heart rate and blood pressure in thyroid malfunctioning La Nouvelle Presse Medicale 3(13): 785-788
Khan, N.A.; McAlister, F.A.; Lewanczuk, R.Z.; Touyz, R.M.; Padwal, R.; Rabkin, S.W.; Leiter, L.A.; Lebel, M.; Herbert, C.; Schiffrin, E.L.; Herman, R.J.; Hamet, P.; Fodor, G.; Carruthers, G.; Culleton, B.; DeChamplain, J.; Pylypchuk, G.; Logan, A.G.; Gledhill, N.; Petrella, R.; Campbell, N.R.C.; Arnold, M.; Moe, G.; Hill, M.D.; Jones, C.; Larochelle, P.; Ogilvie, R.I.; Tobe, S.; Houlden, R.; Burgess, E.; Feldman, R.D. 2005: The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy Canadian Journal of Cardiology 21(8): 657-672
Werning, C.; Stiel, D.; Hammann, K.; Schweikert, H.U.; Fischer, N.; Siegenthaler, W. 1972: SP 54 therapy in hypertension. The effect of SP 54 on blood pressure, renin and aldosterone as well as electrolyte balance in patients with hypertension Fortschritte der Medizin 90(20): 785-787
Tamura, K.; Yutoh, J.; Matsushita, K.; Sakai, M.; Oshikawa, J. 2015: Hypertension with chronic kidney disease: anti-hypertensive therapy recommended for the management of hypertension with CKD in JSN-CKD GL 2013 and JSH2014 Nihon Rinsho. Japanese Journal of Clinical Medicine 73(11): 1876-1884
Kaufman, D.W.; Kelly, J.P.; Rosenberg, L.; Stolley, P.D.; Schottenfeld, D.; Shapiro, S. 1987: Hydralazine and breast cancer Journal of the National Cancer Institute 78(2): 243-246
Mehrotra, T.N.; Raka, M.S.; Mithal, R.; Mehrotra, A. 1986: Hydralazine induced necrotizing vasculitis Journal of the Association of Physicians of India 34(7): 502-503
Halawa, B.; Mazurek, W. 1986: Interaction of digoxin with hydralazine and prazosin Polski Tygodnik Lekarski 41(48): 1521-1523
Ferreira, C.; Murad, N.; Póvoa, R.; Luna, B.; Simões, M.d.J.; Mora, O.A.; Ferreira, C.; Ferreira, M. 1995: A myocardial lesion induced by hydralazine Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 14(11): 853-858
Beickert, A.; Wiesenthal, F.; Franow, K.J. 1970: Effect of hydralazine treatment on the LE phenomenon in NZB and a mice Das Deutsche Gesundheitswesen 25(7): 290-292
Suzuki, H. 2015: Hypertension: The Points of Management of Hypertension for All Physicians--Based on the JSH 2014 Hypertension Guidelines--. Topics: VI. Pregnancy-induced hypertension Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 104(2): 247-252
Seidel, C.L.; Allen, J.C.; Bowers, R.L. 1980: Mechanical and biochemical alterations of aorta induced by hydralazine hypotension Journal of Pharmacology and Experimental Therapeutics 213(3): 514-519
Lanas, F.; Salvatici, R.; Opazo, J.A.; Saavedra, J.; Iturriaga, J. 1979: Treatment of advanced heart failure with hydralazine and isosorbide dinitrate Revista Medica de Chile 107(10): 926-930
Florenzano, F.; Solé, C.; Escobar, E.; Morales, B. 1987: Effect of hydralazine on the ventricular function in chronic aortic insufficiency Revista Medica de Chile 115(4): 289-294